Aqua Pharmaceuticals CEO Gooding Retires

Aqua Pharmaceuticals co-founder Jay Gooding is retiring as CEO of the 8-year-old specialty pharmaceuticals company early next month. Fellow co-founder Craig Ballaron, Aqua’s president, will continue in his president’s role and take on the CEO position. Gooding decided to retire to spend more time with his family and focus on pursuing other passions, including his charity work.

Back to news